Home ImmunOs Therapeutics

ImmunOs Therapeutics

In operation
Series C
Developer of Human Immune Modulatory Proteins

Basic Information

ImmunOs Therapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of next-generation and novel human immune-modulatory proteins that play a role in both innate and adaptive immunity. Their mission is to develop next-generation novel therapies to improve the lives of patients with serious diseases.
ImmunOs Therapeutics AG
Zurich,Switzerland
unclear
January 01, 2014
info@immunos­therapeutics.com